Chemotherapy-induced Neutropenia
📧 Sign up to get email alerts when something new happens for Chemotherapy-induced Neutropenia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-10-24Clinical Trial Update: Dose-finding Study of Empegfilgrastim for Neutropenia Prophylaxis in Patients With Breast Cancer [Phase 2]
This update reports results from a Phase 2 dose-finding trial of Empegfilgrastim for preventing chemotherapy-induced neutropenia in breast c…
-
CLINICAL_TRIALS trial_result · 2016-03-15Clinical Trial Update: Evaluation of the Food Effect on the Safety, Tolerability, PK of EC-18 After Oral Administration in Healthy Volunteers [Phase 1]
This Phase 1 study evaluated how food affects the safety, tolerability, and pharmacokinetics of EC-18 administered orally in healthy volunte…
-
CLINICAL_TRIALS trial_result · 2016-02-24Clinical Trial Update: Safety and Pharmacokinetic(PK) Study of GW003 to Metastatic Tumors [Phase 1]
Phase 1 safety and pharmacokinetic study of GW003 in metastatic tumors, including patients with chemotherapy-induced neutropenia.
-
CLINICAL_TRIALS trial_result · 2016-01-27Clinical Trial Update: Study to Evaluate the Safety, Tolerability and PK of EC-18 After Oral Administration in Healthy Volunteers [Phase 1]
This document reports the completion of a Phase 1 study evaluating the safety, tolerability and pharmacokinetics of EC-18 following oral adm…
-
CLINICAL_TRIALS trial_result · 2016-01-11Clinical Trial Update: A Safety and PK Study of EC-18 in Healthy Subjects [Phase 1]
This Phase 1 study reports safety and pharmacokinetic data for EC-18 in healthy subjects, evaluating tolerability and PK parameters in a fir…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2015-04-07Clinical Trial Update: Phase III Study Comparing the Efficacy and Safety of EP2006 and Filgrastim [Phase 3]
Phase III study comparing EP2006 to filgrastim in patients with chemotherapy-induced neutropenia and breast cancer, assessing efficacy and s…
-
CLINICAL_TRIALS trial_result · 2014-10-01Clinical Trial Update: Phase II Study of DA-3031(PEG-G-CSF) in Chemotherapy-induced Neutropenia [Phase 2]
A Phase II study of DA-3031 (PEG-G-CSF) for chemotherapy-induced neutropenia has completed.
-
CLINICAL_TRIALS trial_result · 2014-10-01Clinical Trial Update: Phase III Study of DA-3031(PEG-G-CSF) in Chemotherapy-induced Neutropenia [Phase 3]
Phase III trial evaluating DA-3031, a pegylated G-CSF, for chemotherapy-induced neutropenia has been completed.
-
CLINICAL_TRIALS trial_result · 2013-11-06Clinical Trial Update: GCPGC in Chemotherapy-induced Neutropenia [Phase 2, Phase 3]
A completed Phase 2/Phase 3 trial of GCPGC for chemotherapy-induced neutropenia is reported.
-
CLINICAL_TRIALS trial_result · 2011-05-13Clinical Trial Update: G-CSF in Preventing Neutropenia in Women Receiving Chemotherapy for Breast Cancer [Phase 2]
Phase 2 trial evaluating whether granulocyte colony-stimulating factor can prevent chemotherapy-induced neutropenia in women with breast can…
-
CLINICAL_TRIALS trial_result · 2011-01-27Clinical Trial Update: A Study Comparing Pegylated Filgrastim and Filgrastim in Support for Chemotherapy [Phase 3]
A Phase 3 trial comparing pegfilgrastim with filgrastim in cancer patients receiving chemotherapy has completed. The study evaluated efficac…
-
CLINICAL_TRIALS trial_result · 2010-02-03Clinical Trial Update: Safety and Efficacy Trial of Recombinant Human Granulocyte Colony Stimulating Factor (GCSF) [Phase 3]
A Phase 3 trial evaluating the safety and efficacy of recombinant human G-CSF for chemotherapy-induced neutropenia has completed.
-
CLINICAL_TRIALS trial_result · 2007-08-30Clinical Trial Update: Study on Mannan Binding Lectin (MBL) Substitution in MBL-Deficient Children With Chemotherapy-Induced Neutropenia [Phase 2]
Phase 2 trial evaluating Mannan-binding lectin substitution in MBL-deficient children with chemotherapy-induced neutropenia has been complet…